CHARACTERIZATION WITH HALOPERIDOL-H-3 OF THE DOPAMINE RECEPTOR IN THE RAT-KIDNEY PARTICULATE PREPARATION

被引:16
作者
NAKAJIMA, T
KURUMA, I
机构
关键词
D O I
10.1254/jjp.30.891
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:891 / 898
页数:8
相关论文
共 24 条
[1]   2 BINDING-SITES FOR H-3-SPIROPERIDOL ON RAT STRIATAL MEMBRANES [J].
BRILEY, M ;
LANGER, SZ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 50 (03) :283-284
[3]  
BURT DR, 1976, MOL PHARMACOL, V12, P800
[4]  
CARON MG, 1978, J BIOL CHEM, V253, P2244
[5]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[6]   H-3-SPIROPERIDOL LABELS SEROTONIN RECEPTORS IN RAT CEREBRAL-CORTEX AND HIPPOCAMPUS [J].
CREESE, I ;
SNYDER, SH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 49 (02) :201-202
[7]   STEREOSPECIFICITY OF INTERACTION OF NEUROLEPTIC DRUGS WITH NEUROTRANSMITTERS AND CORRELATION WITH CLINICAL POTENCY [J].
ENNA, SJ ;
BENNETT, JP ;
BURT, DR ;
CREESE, I ;
SNYDER, SH .
NATURE, 1976, 263 (5575) :338-341
[8]  
GOLDBERG LI, 1972, PHARMACOL REV, V24, P1
[9]   COMPARISON OF VASCULAR DOPAMINE RECEPTOR WITH OTHER DOPAMINE RECEPTORS [J].
GOLDBERG, LI ;
VOLKMAN, PH ;
KOHLI, JD .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1978, 18 :57-79
[10]  
GRAY EG, 1962, J ANAT, V96, P79